PGSD, SNO and ASCO are big, ESMO is medium and these are congresses. Phacylitate is a tiny conference for highly specialized scientists and industry.
Go to SNO or go back to court. That is the option she has now. While she may win another round of court cases, where will she get the capital to fight and stall retail investors some more. Who will invest new money when the ambulance chasers come back? Which one of us will sign as as lead plaintiff? Who will LL side with and what does she have to say when she receives a subpoena?
IDEC sold Rituxin and follow on products to Genetech for $200M and substantial royalties. Rituxin was the largest grossing drug in history before Humira displaced that title. Biogen Idec kicked themselves for decades later and small biotechs literally quoted that deal as the example why they wanted to go it alone for years and years…most all are no longer around either from self-combustion or later acquisition while Biogen was one of the big 3 biotechs for decades. They would not have made it without Rituxin deal money and Genetech’s marketing prowess. I would call that going big considering their market cap is in the neighborhood of $80B today and combined the BIIB combo was worth less than $1B at the time of the Rituxin deal. Without the deal, they likely would have been going home after pulling Tysabri from market.
Is there anyone bigger than Merk, BMS, JNJ, Roche or Novartis? Well, yes Tesla, Microsoft, Amazon and Alphbet but not any start up biotechs. Amgen is close I guess, maybe Gilead. Going BIG would have been striking a deal for DCVax-L and developing DCVax-D.
Do you realize that we could be anticipating the first Direct approval right now instead of waiting on data for L if they had the cash to actually run an efficient Biotech business? It has been on the shelf for more than 6 years now…I am getiing to the point where I want LP to go the frack home and allow us to go big, but it may be too late for that already. Time is money and mRNA is around the courner. You wanna bet on who has more oncology approvals in 4 years, Moderna or NWBO?
My money should have been on Moderna all along. I just didn’t have the free cash available when they were $50 and offered me a job. Mainly because I have been bound and gagged by LP. I also should have taken that job, but hindsight is 20-20 and I like my current digs quite a lot as well. I just would have liked the jackpot more.
